1. Home
  2. WVE vs JAMF Comparison

WVE vs JAMF Comparison

Compare WVE & JAMF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WVE
  • JAMF
  • Stock Information
  • Founded
  • WVE 2012
  • JAMF 2002
  • Country
  • WVE Singapore
  • JAMF United States
  • Employees
  • WVE N/A
  • JAMF N/A
  • Industry
  • WVE Biotechnology: Pharmaceutical Preparations
  • JAMF Computer Software: Prepackaged Software
  • Sector
  • WVE Health Care
  • JAMF Technology
  • Exchange
  • WVE Nasdaq
  • JAMF Nasdaq
  • Market Cap
  • WVE 939.3M
  • JAMF 1.4B
  • IPO Year
  • WVE 2015
  • JAMF 2020
  • Fundamental
  • Price
  • WVE $6.54
  • JAMF $11.29
  • Analyst Decision
  • WVE Strong Buy
  • JAMF Buy
  • Analyst Count
  • WVE 11
  • JAMF 9
  • Target Price
  • WVE $20.91
  • JAMF $19.89
  • AVG Volume (30 Days)
  • WVE 1.7M
  • JAMF 734.6K
  • Earning Date
  • WVE 05-08-2025
  • JAMF 05-06-2025
  • Dividend Yield
  • WVE N/A
  • JAMF N/A
  • EPS Growth
  • WVE N/A
  • JAMF N/A
  • EPS
  • WVE N/A
  • JAMF N/A
  • Revenue
  • WVE $104,939,000.00
  • JAMF $642,897,000.00
  • Revenue This Year
  • WVE N/A
  • JAMF $9.86
  • Revenue Next Year
  • WVE N/A
  • JAMF $8.49
  • P/E Ratio
  • WVE N/A
  • JAMF N/A
  • Revenue Growth
  • WVE N/A
  • JAMF 10.75
  • 52 Week Low
  • WVE $4.25
  • JAMF $9.95
  • 52 Week High
  • WVE $16.74
  • JAMF $21.41
  • Technical
  • Relative Strength Index (RSI)
  • WVE 42.23
  • JAMF 45.49
  • Support Level
  • WVE $6.30
  • JAMF $10.64
  • Resistance Level
  • WVE $8.39
  • JAMF $12.67
  • Average True Range (ATR)
  • WVE 0.66
  • JAMF 0.49
  • MACD
  • WVE 0.10
  • JAMF 0.08
  • Stochastic Oscillator
  • WVE 33.21
  • JAMF 40.77

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About JAMF Jamf Holding Corp.

Jamf Holding Corp is the standard in Apple Enterprise Management, and its cloud software platform is the vertically focused Apple infrastructure and security platform. The company helps organizations, including businesses, hospitals, schools, and government agencies, connect, manage, and protect Apple products, apps, and corporate resources in the cloud without ever having to touch the devices. It sells its Software-as-a-Service, or SaaS, solutions via a subscription model, through a direct sales force, online, and indirectly via its channel partners, including Apple. The company operates in The Americas; Europe, the Middle East, India, and Africa; and Asia Pacific.

Share on Social Networks: